SCHEMBL346766

SCHEMBL346766

C=CCCCCCCCC(=O)OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
ALDH1A1 P00352 2/20 1.00
MAPT P10636 2/20 0.57
ABCC4 O15439 1/20 0.57
TSHR P16473 5/20 0.56
EPHX2 P34913 1/20 0.50
POLB P06746 1/20 0.46
POLA1 P09884 1/20 0.46
RECQL P46063 2/20 0.45
USP2 O75604 1/20 0.44
CYP3A4 P08684 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TRPV1 Q8NER1 1/20 0.43
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3034063 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL817047 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL11326603 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL21352704 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL21352709 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL515291 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL9244114 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL9329621 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL196188 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR
SCHEMBL490162 1.00 LMNA (1.00) LMNAALDH1A1MAPTABCC4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12486468-B2 Method for the preparation of omega-amino-carboxylic acids and derivatives thereof VERSALIS S.P.A. (IT) 2025-12-02 US claimed
US-20250257373-A1 BIO-OXIDATION PROCESS FOR THE PREPARATION OF ALKANEDIOIC ACIDS EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) 2025-08-14 US claimed
EP-4464686-B1 PROCESS FOR THE PREPARATION OF AN ACETAL FROM AN OLEFIN USING TTI2 OR PTBR2 EVONIK OXENO GMBH & CO KG (DE) 2025-07-16 EP claimed
EP-3724307-B1 LAUNDRY SURFACTANTS HAVING INHERENT BUILDING CAPACITY DERIVED FROM BIO-BASED HYDROYACIDS AND EPOXIDES; AND PROCESS THEREFORE BATTELLE MEMORIAL INSTITUTE (US) 2025-07-16 EP claimed
EP-4464687-B1 PROCESS FOR THE PREPARATION OF AN ACETAL FROM AN OLEFIN USING AN IODINE ALKYL COMPOUND EVONIK OXENO GMBH & CO KG (DE) 2025-07-09 EP claimed
CN-119930697-A Benzylidene o-halogenated Ru olefin metathesis catalyst and preparation and application thereof 中国石油天然气股份有限公司 2025-05-06 CN claimed
CN-119930696-A Imidazole coordinated ruthenium carbene olefin metathesis catalyst, preparation and application thereof 中国石油天然气股份有限公司 2025-05-06 CN claimed
CN-119912198-A Composite drag-reducing viscosity-reducing concrete for high-lift pumping and preparation method thereof 交通运输部公路科学研究所 2025-05-02 CN claimed
US-20250136887-A1 METHOD FOR THE PREPARATION OF OMEGA-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF VERSALIS S.P.A. (IT) 2025-05-01 US claimed
CN-118993851-A Process for preparing acetals from olefins by using iodinated alkyl compounds 赢创奥克森诺有限责任两合公司 2024-11-22 CN claimed
US-20050080301-A1 Process for the synthesis of unsaturated alcohols DOW GLOBAL TECHNOLOGIES LLC 2005-04-14 US claimed
US-20050070750-A1 Metathesis of unsaturated fatty acid esters or unsaturated fatty acids with lower olefins DOW GLOBAL TECHNOLOGIES LLC 2005-03-31 US claimed
EP-1501784-A1 INTERGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS DOW GLOBAL TECHNOLOGIES INC. (US) 2005-02-02 EP claimed
US-20040260043-A1 Olefin polymerization catalyst system useful for polar monomers EXXONMOBIL CHEMICAL PATENTS, INC. 2004-12-23 US claimed
WO-2004101634-A1 OLEFIN POLYMERIZATION CATALYST SYSTEM USEFUL FOR POLAR MONOMERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-11-25 WO claimed
EP-1377537-A1 METATHESIS OF UNSATURATED FATTY ACID ESTERS OR UNSATURATED FATTY ACIDS WITH LOWER OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2004-01-07 EP claimed
WO-2003093215-A1 INTERGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS DOW GLOBAL TECHNOLOGIES INC. (US) 2003-11-13 WO claimed
WO-2002076920-A1 METATHESIS OF UNSATURATED FATTY ACID ESTERS OR UNSATURATED FATTY ACIDS WITH LOWER OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2002-10-03 WO claimed
EP-0057736-B1 OLEFIN DISPROPORTIONATION PROCESS AND CATALYST PHILLIPS PETROLEUM COMPANY (US) 1986-11-20 EP claimed
US-4269780-A CATALYSTS COMPRISING CARBENE METAL COMPLEXES AND METAL HALIDES AND OXYHALIDES AS ACTIVATORS; POLYMERIZATION INHIBITION PHILLIPS PETROLEUM COMPANY (US) 1981-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080301-A1 Process for the synthesis of unsaturated alcohols FASN, SQLE, ALOX12 LMNA 1317/4885ALDH1A1 821/4885MAPT 3112/4885
US-20250257373-A1 BIO-OXIDATION PROCESS FOR THE PREPARATION OF ALKANEDIOIC ACIDS SCD, ELOVL3, ALOX15B LMNA 2110/4885ALDH1A1 264/4885MAPT 4695/4885
US-20050070750-A1 Metathesis of unsaturated fatty acid esters or unsaturated fatty acids with lower olefins ALOX12, ALOX15, ALOX5 LMNA 3639/4885ALDH1A1 1410/4885MAPT 3299/4885
US-12486468-B2 Method for the preparation of omega-amino-carboxylic acids and derivatives thereof FADS1, ABHD6, FASN LMNA 1843/4885ALDH1A1 864/4885MAPT 4479/4885
US-20250136887-A1 METHOD FOR THE PREPARATION OF OMEGA-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF FADS1, ABHD6, FASN LMNA 1843/4885ALDH1A1 864/4885MAPT 4479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.